BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barantsevich N, Barantsevich E. Diagnosis and Treatment of Invasive Candidiasis. Antibiotics 2022;11:718. [DOI: 10.3390/antibiotics11060718] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Kaur J, Nobile CJ. Antifungal drug-resistance mechanisms in Candida biofilms. Current Opinion in Microbiology 2023;71:102237. [DOI: 10.1016/j.mib.2022.102237] [Reference Citation Analysis]
2 De Bels D, Maillart E, Van Bambeke F, Redant S, Honoré PM. Existing and emerging therapies for the treatment of invasive candidiasis and candidemia. Expert Opinion on Emerging Drugs 2022. [DOI: 10.1080/14728214.2022.2142207] [Reference Citation Analysis]
3 Li H, Yang J, Zhang X, Xu X, Song F, Li H. Biocontrol of Candida albicans by Antagonistic Microorganisms and Bioactive Compounds. Antibiotics 2022;11:1238. [DOI: 10.3390/antibiotics11091238] [Reference Citation Analysis]
4 Rivera-yañez CR, Ruiz-hurtado PA, Reyes-reali J, Mendoza-ramos MI, Vargas-díaz ME, Hernández-sánchez KM, Pozo-molina G, Méndez-catalá CF, García-romo GS, Pedroza-gonzález A, Méndez-cruz AR, Nieto-yañez O, Rivera-yañez N. Antifungal Activity of Mexican Propolis on Clinical Isolates of Candida Species. Molecules 2022;27:5651. [DOI: 10.3390/molecules27175651] [Reference Citation Analysis]
5 Costa PDS, Prado A, Bagon NP, Negri M, Svidzinski TIE. Mixed Fungal Biofilms: From Mycobiota to Devices, a New Challenge on Clinical Practice. Microorganisms 2022;10:1721. [DOI: 10.3390/microorganisms10091721] [Reference Citation Analysis]
6 Enache A, Cojocaru C, Samoila P, Bele A, Bostanaru A, Mares M, Harabagiu V. Evaluation of Physically and/or Chemically Modified Chitosan Hydrogels for Proficient Release of Insoluble Nystatin in Simulated Fluids. Gels 2022;8:495. [DOI: 10.3390/gels8080495] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]